Quick Answer
Protagonist Therapeutics, Inc reported Shares Outstanding of 62.58 million shares for fiscal year 2025.
Protagonist Therapeutics, Inc Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 62.58M | +2.5% |
| 2024 | 61.04M | +5.8% |
| 2023 | 57.71M | +17.0% |
| 2022 | 49.34M | +3.1% |
| 2021 | 47.84M | +9.4% |
| 2020 | 43.75M | +60.7% |
| 2019 | 27.22M | +17.4% |
| 2018 | 23.19M | +10.0% |
| 2017 | 21.09M | +26.1% |
| 2016 | 16.72M | +6038.7% |
| 2015 | 272,409 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 62.45M | +4.9% | +0.5% |
| June 30, 2025 | 62.11M | +5.7% | +0.3% |
| March 31, 2025 | 61.93M | +5.7% | +1.5% |
| December 31, 2024 | 61.04M | +5.8% | +2.5% |
| September 30, 2024 | 59.52M | +3.3% | +1.3% |
| June 30, 2024 | 58.76M | +2.2% | +0.3% |
| March 31, 2024 | 58.60M | +13.9% | +1.5% |
| December 31, 2023 | 57.71M | +17.0% | +0.1% |
- Protagonist Therapeutics, Inc showed an increase of +2.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2015–2025 period, Protagonist Therapeutics, Inc’s shares outstanding has grown by 22872.0% (from 272.4 thousand shares to 62.58 million shares).
- The most recent figure is from Protagonist Therapeutics, Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: